Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xian Chen, Wenni Dai, Hao Li, Zhe Yan, Zhiwen Liu & Liyu He. (2023) Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease. Drug Delivery 30:1.
Read now
Read now
Qili Wang, Shunping Han, Yongqin Zhu, Guowei Wang & Danfei Chen. (2023) Poly-γ-glutamic acid coating polymeric nanoparticles enhance renal drug distribution and cellular uptake for diabetic nephropathy therapy. Journal of Drug Targeting 31:1, pages 89-99.
Read now
Read now
Chunkang Liu, Kunzhe Wu, Huan Gao, Jianyang Li & Xiaohua Xu. (2022) Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy. Diabetes, Metabolic Syndrome and Obesity 15, pages 2653-2673.
Read now
Read now
Milad Ashrafizadeh, Alan Prem Kumar, Amir Reza Aref, Ali Zarrabi & Ebrahim Mostafavi. (2022) Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications. International Journal of Nanomedicine 17, pages 1229-1253.
Read now
Read now
Articles from other publishers (43)
Shunlai Shang, Xiangmeng Li, Haoran Wang, Yena Zhou, Keying Pang, Ping Li, Xiaomin Liu, Min Zhang, Wenge Li, Qinggang Li & Xiangmei Chen. (2024) Targeted therapy of kidney disease with nanoparticle drug delivery materials. Bioactive Materials 37, pages 206-221.
Crossref
Crossref
Anastasiia Vasylaki, Pratyusha Ghosh, Edgar A. Jaimes & Ryan M. Williams. (2024) Targeting the Kidneys at the Nanoscale: Nanotechnology in Nephrology. Kidney360 5:4, pages 618-630.
Crossref
Crossref
Jinghua Sun, Juanjuan Han, Jie Dong, Xiaoyan Zhai & Ruiping Zhang. (2024) A kidney-targeted chitosan-melanin nanoplatform for alleviating diabetic nephropathy through modulation of blood glucose and oxidative stress. International Journal of Biological Macromolecules 264, pages 130663.
Crossref
Crossref
Hao Tian, Liulin Wu, Haoxiang Qin, Xiaochen Li, Xingli Zhao, Wenyan Zhao, Fangchao Xue, Shanlan Zhao, Lang Li & Wen Zeng. (2024) Composite materials combined with stem cells promote kidney repair and regeneration. Composites Part B: Engineering 275, pages 111278.
Crossref
Crossref
Chenxin Liu, Mengxue Pang, Qingyu Wang, Mei Yan, Yingying Zhou, Hanchun Yao & Bin Du. (2024) Intestinal Absorption of Nanoparticles to Reduce Oxidative Stress and Vasoconstriction for Treating Diabetic Nephropathy. ACS Biomaterials Science & Engineering 10:3, pages 1517-1529.
Crossref
Crossref
Prapti Chakraborty & Priyanka Ray. 2024. Nanocellulose. Nanocellulose
297
318
.
He-Qin Zhan, Xiaoxun Zhang, Xu-Lin Chen, Liang Cheng & Xianwen Wang. (2024) Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives. Journal of Nanobiotechnology 22:1.
Crossref
Crossref
Sida Huang, Hanqi Lu, Jin Chen, Chengyi Jiang, Guanmin Jiang, Govindhan Maduraiveeran, Ying Pan, Jianqiang Liu & Li-Er Deng. (2024) Advances in drug delivery-based therapeutic strategies for renal fibrosis treatment. Journal of Materials Chemistry B.
Crossref
Crossref
Di Jia, Jiahui Han, Jimin Cai, Zhirong Huan, Yan Wang & Xin Ge. (2024) Mesenchymal stem cells overexpressing PBX1 alleviates haemorrhagic shock-induced kidney damage by inhibiting NF-κB activation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1871:1, pages 119571.
Crossref
Crossref
Ahmad Vaez, Ali Mohammad Amani, Majid Salehi, Zeinab Zarei-Behjani, Alireza Rezvani, Hengameh Dourtaj, Alireza Hooshmand-Ardakani & Zohreh Arabpour. 2024. Nanomedicine in Cancer Immunotherapy. Nanomedicine in Cancer Immunotherapy
71
110
.
Nurul JummahSatrialdi SatrialdiAluicia Anita ArtariniAnindyajati AnindyajatiDiky Mudhakir. (2023) Diabetic Nephropathy: Pathogenesis and Drug Delivery System. Research Journal of Pharmacy and Technology, pages 6062-6070.
Crossref
Crossref
SYED SAIF IMAM. (2023) NANOPARTICLES: THE FUTURE OF DRUG DELIVERY. International Journal of Current Pharmaceutical Research, pages 8-15.
Crossref
Crossref
Paramita Paul, Leena Chacko, Tarun K. Dua, Pratik Chakraborty, Udita Paul, Vishwakarma Vishal Phulchand, Niraj K. Jha, Saurabh K. Jha, Ramesh Kandimalla & Saikat Dewanjee. (2023) Nanomedicines for the management of diabetic nephropathy: present progress and prospects. Frontiers in Endocrinology 14.
Crossref
Crossref
Xia Yang, Han Xiao, Jiao He, Li Yang, Zhu Tao, Xin Xiao, Qiu Li & Hai-ping Yang. (2023) A novel pillar[5]arene-based supramolecular fluorescent biomaterial for targeted accumulation and imaging of kidney. Sensors and Actuators B: Chemical 392, pages 134065.
Crossref
Crossref
Xi Mao, Ding-qiao Xu, Shi-jun Yue, Rui-jia Fu, Sai Zhang & Yu-ping Tang. (2023) Potential Medicinal Value of Rhein for Diabetic Kidney Disease. Chinese Journal of Integrative Medicine 29:10, pages 951-960.
Crossref
Crossref
Ritika Sharma, Shikha Jyoti Borah, Bhawna, Sanjeev Kumar, Akanksha Gupta, Vandana Kumari, Ravinder Kumar, Kashyap Kumar Dubey & Vinod Kumar. (2023) Emerging trends in nano-based antidiabetic therapeutics: a path to effective diabetes management. Materials Advances 4:15, pages 3091-3113.
Crossref
Crossref
Javier Avendaño-Godoy, Maria Gabriela Poblete, Ricardo Godoy Ramos & Carolina Gómez-Gaete. (2023) Evaluation of the Effects of Gamma Radiation Sterilization on Rhein-Loaded Biodegradable Microparticles for the Treatment of Osteoarthritis. Journal of Pharmaceutical Sciences 112:3, pages 837-843.
Crossref
Crossref
Shiyu Yang, Zhiqiong Chen, Ping Zhou, Jiashan Xia, Tao Deng & Chao Yu. (2023) Carbon dots based on endogenous nutrients with visible and NIR fluorescence to penetrate blood-brain barrier. Carbon 202, pages 130-140.
Crossref
Crossref
Selvaraj Kunjiappan, Theivendren Panneerselvam, Sureshbabu Ram Kumar Pandian, Parasuraman Pavadai, Saravanan Govindaraj, Vigneshwaran Ravishankar, Sankarganesh Arunachalam & Sankaranarayanan Murugesan. 2023. Emerging Nanotechnologies for Medical Applications. Emerging Nanotechnologies for Medical Applications
95
130
.
Rachel Chapla, Katherine T. Huynh & Carolyn E. Schutt. (2022) Microbubble–Nanoparticle Complexes for Ultrasound-Enhanced Cargo Delivery. Pharmaceutics 14:11, pages 2396.
Crossref
Crossref
Haihan Sun, Kun Shi, Bangjie Zuo, Xin Zhang, Yue Liu, Dong Sun & Fengzhen Wang. (2022) Kidney-Targeted Drug Delivery System Based on Metformin-Grafted Chitosan for Renal Fibrosis Therapy. Molecular Pharmaceutics 19:9, pages 3075-3084.
Crossref
Crossref
Alejandro R. Chade & Gene L. BidwellIIIIII. (2022) Novel Drug Delivery Technologies and Targets for Renal Disease. Hypertension 79:9, pages 1937-1948.
Crossref
Crossref
Moustafa Mahmoud Hamdy, Mahran S. Abdel-Rahman, Dalia M. Badary & Mahmoud S. Sabra. (2022) Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats. European Journal of Medical Research 27:1.
Crossref
Crossref
Luke Tillman, Tanveer A. Tabish, Nazila Kamaly, Primrose Moss, Amal El-briri, Christoph Thiemermann, Md Zahidul I. Pranjol & Muhammad M. Yaqoob. (2022) Advancements in nanomedicines for the detection and treatment of diabetic kidney disease. Biomaterials and Biosystems 6, pages 100047.
Crossref
Crossref
Olga I. Gusliakova, Ekaterina S. Prikhozhdenko, Valentina O. Plastun, Oksana A. Mayorova, Natalia A. Shushunova, Arkady S. Abdurashitov, Oleg A. Kulikov, Maxim A. Abakumov, Dmitry A. Gorin, Gleb B. Sukhorukov & Olga A. Sindeeva. (2022) Renal Artery Catheterization for Microcapsules’ Targeted Delivery to the Mouse Kidney. Pharmaceutics 14:5, pages 1056.
Crossref
Crossref
Yu Huang, Zhishi Xu, Yinghui Wei, Shunping Han, Xinjun Cai & Danfei Chen. (2022) Albumin-Embellished Arsenic Trioxide-Loaded Polymeric Nanoparticles Enhance Tumor Accumulation and Anticancer Efficacy via Transcytosis for Hepatocellular Carcinoma Therapy. AAPS PharmSciTech 23:4.
Crossref
Crossref
Qingsi Wu, Jiading Wang, Yuanfang Wang, Ling Xiang, Yulu Tan, Jiaxing Feng, Zhirong Zhang & Ling Zhang. (2021) Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment. Nano Research 15:4, pages 3556-3568.
Crossref
Crossref
Zaed M. Mazayen, Amira M. Ghoneim, Rasha S. Elbatanony, Emad B. Basalious & Ehab R. Bendas. (2022) Pharmaceutical nanotechnology: from the bench to the market. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
Çiğdem Yücel & Gökçe Şeker Karatoprak. 2022. The Role of Phytonutrients in Metabolic Disorders. The Role of Phytonutrients in Metabolic Disorders
67
102
.
Alazne Moreno-Lanceta, Mireia Medrano-Bosch, Elazer R. Edelman & Pedro Melgar-Lesmes. 2022. Pharmaceutical Nanobiotechnology for Targeted Therapy. Pharmaceutical Nanobiotechnology for Targeted Therapy
561
608
.
Yuntao Liu, Siqi Zeng, Wei Ji, Huan Yao, Lin Lin, Haiying Cui, Hélder A. Santos & Guoqing Pan. (2021) Emerging Theranostic Nanomaterials in Diabetes and Its Complications. Advanced Science 9:3.
Crossref
Crossref
Miaoyuan Zhang, Liyu He, Jingsong Liu & Lin Zhou. (2020) Luteolin Attenuates Diabetic Nephropathy
through Suppressing Inflammatory Response and
Oxidative Stress by Inhibiting STAT3
Pathway. Experimental and Clinical Endocrinology & Diabetes 129:10, pages 729-739.
Crossref
Crossref
Marwa Hasanein Asfour, Abeer A.A. Salama & Amira Mohamed Mohsen. (2021) Fabrication of All-Trans Retinoic Acid loaded Chitosan/Tripolyphosphate Lipid Hybrid Nanoparticles as a Novel Oral Delivery Approach for Management of Diabetic Nephropathy in Rats. Journal of Pharmaceutical Sciences 110:9, pages 3208-3220.
Crossref
Crossref
Li Cheng, Qiuhe Chen, Rongbiao Pi & Jingkao Chen. (2021) A research update on the therapeutic potential of rhein and its derivatives. European Journal of Pharmacology 899, pages 173908.
Crossref
Crossref
Yanan Wang, Chunhui Wang, Keyang Li, Xinyu Song, Xuefeng Yan, Liangmin Yu & Zhiyu He. (2021) Recent advances of nanomedicine-based strategies in diabetes and complications management: Diagnostics, monitoring, and therapeutics. Journal of Controlled Release 330, pages 618-640.
Crossref
Crossref
Lei Zhang, Lina Gao & Hongzhi Qiao. 2021. Novel Drug Delivery Systems for Chinese Medicines. Novel Drug Delivery Systems for Chinese Medicines
133
151
.
Tianjun Guan, Fan Fang, Xiaoxuan Su, Kaiqiang Lin & Qing Gao. (2020) Silencing PEG3 inhibits renal fibrosis in a rat model of diabetic nephropathy by suppressing the NF-κB pathway. Molecular and Cellular Endocrinology 513, pages 110823.
Crossref
Crossref
Fatemeh Oroojalian, Fahimeh Charbgoo, Maryam Hashemi, Amir Amani, Rezvan Yazdian-Robati, Ahad Mokhtarzadeh, Mohammad Ramezani & Michael R. Hamblin. (2020) Recent advances in nanotechnology-based drug delivery systems for the kidney. Journal of Controlled Release 321, pages 442-462.
Crossref
Crossref
Nidhi Raval, Akshant Kumawat, Dnyaneshwar Kalyane, Kiran Kalia & Rakesh K. Tekade. (2020) Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities. Drug Discovery Today 25:5, pages 862-878.
Crossref
Crossref
Vineet Kumar Rai, Raj Kumar Narang, Faheem Hyder Pottoo & Md Abul Barkat. 2020. Nanophytomedicine. Nanophytomedicine
133
149
.
Heng-Chang Hu, Liu-Tao Zheng, Hai-Yan Yin, Yuan Tao, Xiao-Qiong Luo, Kai-Shan Wei & Li-Ping Yin. (2019) A Significant Association Between Rhein and Diabetic Nephropathy in Animals: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 10.
Crossref
Crossref
Nidhi Raval, Hardi Jogi, Piyush Gondaliya, Kiran Kalia & Rakesh K. Tekade. (2019) Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In vitro- In vivo Assessment. Scientific Reports 9:1.
Crossref
Crossref
Virna Margarita Martín Giménez, Lucía Beatriz Fuentes, Diego Enrique Kassuha & Walter Manucha. (2019) Current Drug Nano-targeting Strategies for Improvement in the Diagnosis and Treatment of Prevalent Pathologies such as Cardiovascular and Renal Diseases. Current Drug Targets 20:14, pages 1496-1504.
Crossref
Crossref